India to Tunisia: Serum Export Trade Route

The India to Tunisia Serum corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $1.7M USD. The route is dominated by BHARAT SERUMS AND VACCINES LIMITED, which alone accounts for roughly 78% of all export value, reflecting the consolidated nature of India's serum manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $133.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with serum's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 12.7%, placing it at rank #8 among India's top serum export destinations globally.

On the import side, key buyers of Indian serum in Tunisia include PHARMACIE CENTRALE DE, PHARMACIE CENTRALE DE TUNISIE 51,, PHARMACIE CENTRALE DE and 4 others. PHARMACIE CENTRALE DE is the single largest importer with 6 shipments valued at $1.1M USD.

India's serum exports to Tunisia are driven primarily by a handful of large-scale manufacturers. BHARAT SERUMS AND VACCINES LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Tunisia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BHARAT SERUMS AND VACCINES LIMITED, BHARAT SERUMS AND VACCINES LIMITED , VINS BIOPRODUCTS LIMITED — together account for 99% of total trade value on this route. The average shipment value of $133.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as equirab 1000 iu 5ml rabies antiserum equine and equirab 1000 iu/5mlrabies antiserum - equine, suggesting that buyers in Tunisia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PHARMACIE CENTRALE DE is the largest importer with 6 shipments worth $1.1M USD — representing 64% of all serum imports from India on this route. A total of 7 buyers are active on this corridor.